Worst performer this week was BLUR:Blur Group dropping 11%, but that's of no matter as my shares are practically worthless anyway.
More distressing was the 10% drop in KIBO:Kibo Mining. I really don't understand the negative sentiment towards this share. The bulletin board is crawling with complete lunatics trying their illiterate best to drive the share price down, and normally that's a sign it's about to surge. I really hope so as it's now £1,524.91 in the red and by far my Nemesis Share. Given that a few weeks ago OPTI:Optibiotix was my Nemesis Share with similar losses, but is now £1,116.46 in profit, there's always hope!
Share of the Week was AMYT:Amryt Pharma, climbing 12% and being a major contributor to this week's good performance. The world is waking up to the promise in this company, so I'm confident this is just the start.
Here's the performance of the combined ISA and share accounts
| Weekly Change | |||
| Portfolio cost | £43,056.99 | +£0 | |
| Portfolio sell value (bid price - commission) | £41,971.36 | (-2.5%) | +£782.53 |
| Potential profits | £4,665.85 | +£966.35 | |
| Yr 2 Dividends | £357.10 | +£0 | |
| Yr 2 Profit from sales | £3,404.23 | +£0 | |
| Yr 2 Average monthly cash profit | £476.04 | -£14.42 | |
| Yr 2 Avg annual % of current portfolio cost | 13.3% | ||
| Total Dividends | £1,025.03 | +£0 | |
| Total Profit from sales | £7,244.49 | +£0 | |
| Average monthly cash profit | £412.32 | -£4.85 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 11.5% |
£966 increase in potential profits is wonderful, with KIBO:Kibo Mining the main cause of the portfolio value only climbing by £782. Nothing else happened so a slight tick down on average performance.
That looks so good - a stunning beauty to behold! These accounts have never, ever been in the black. The closest was between weeks 58 and 59 where the deficit was £472. We're still a way off that, with £1,085 difference, but a few more weeks like this one would remove that. The moral of the story is "Don't panic!".
The SIPP looks like this after week 70
| Weekly Change | |||
| Portfolio cost | £16,776.69 | +£0 | |
| Portfolio sell value (bid price - commission) | £19,631.39 | (+17.0%) | -£46.19 |
| Potential profits | £3,453.89 | -£18.05 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £842.07 | +£0 | |
| Yr 2 Average monthly cash profit | £195.98 | -£11.53 | |
| Yr 2 Avg annual % of current portfolio cost | 14.0% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,191.93 | +£0 | |
| Average monthly cash profit | £218.30 | -£3.17 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 15.6% |
The 6% increase in OPTI:Optibiotix was wiped out by a 6% loss in CAML:Central Asia Metals and 3% drop in ARL:Atlantis Resources. Central Asia Metals has dropped so much recently that it's looking like a good time to add more. Preliminary results are due out on Tuesday and if a healthy dividend is announced, the recent dip could be history.
The trading account looks like this after week 36
| Weekly Change | |||
| Portfolio cost | £1,481.98 | +£495.96 | |
| Cash | £79.63 | +£4.04 | |
| Portfolio sell value (bid price - commission) | £1,215.38 | (-18.0%) | -£81.98 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | £61.57 | +£0 | |
| Average monthly cash profit | £7.41 | -£0.21 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 6.0% |
What's this? I had an unexpected windfall from a delayed flight compensation payment. In theory I should have put it towards the deposit for my next holiday, but I've already put that aside, so I thought seeding another £500 into this account might perk it up a bit.
I purchased 9,120 shares in JLP:Jubilee Platinum at 5.34p costing £495.96. I couldn't stand by and watch the share price at this value and not do something. There was so much amazing news this week and last week that I really expected the price to have topped 10p by now. It feels like a volcano swelling, incapable of holding everything in for much longer. When it goes, I think it's going to be spectacular. A surge to 10p would take the market cap past £100m and into the sight of the institutional investors, then there's no stopping it. I want to keep my existing 150,000 shares for the long haul, as I am expecting £1 a share in a few years. This purchase will be to take advantage of the imminent eruption. Or of course, I could be completely wrong...
The other shares in this account did dreadfully so the overall performance is shocking.
Another neat step upwards for cost, and a further widening of the gap for a green line that's spent virtually the whole time below the red.
So, another amazingly exciting week has passed. What is there to look forward to next week?
As mentioned above, preliminary results from CAML:Central Asia Metals could be good news if the dividend is increased. JLP:Jubilee Platinum are on a roll and I'm almost expecting another great RNS every day. KIBO:Kibo Mining surely can't keep dropping so badly, so I'm keeping fingers crossed for something to reverse the drop, and the birth of Katoro Mining could just do that.
All this fades into insignificance compared to the big event on Wednesday - the IPO of SkinBioTherapeutics. My sacrificial shares will be VEC:Vectura which are making a 7% loss, but will liberate £1,062 so I can be there from the start. My worry is that the demand will be so high that I can't buy them quick enough and the price zooms above what I'm willing to pay. What's frustrating is that I wouldn't bother if I knew what was going on with existing OPTI:Optibiotix holders and whether we get free shares. I think we ought to, but there has been no announcement. I'll hold off selling Vectura until the last possible minute in the hope we get some news. Otherwise, Wednesday morning could be a bit fraught...
No comments:
Post a Comment